Clinic-agreement pricing versus pass-through, plainly
A clinic-agreement model sets your drug cost through a negotiation at onboarding. Olympia Pharmacy offers pricing through its DrScript portal and clinical liaison process — the per-vial rate arrives after you contact Olympia and complete onboarding, not at the point you are first evaluating the platform or quoting a patient. That can produce competitive rates for high-volume clinics with an established relationship, which is a real strength. The cost is timing and visibility: you do not see the number at the moment you are quoting a patient on semaglutide or tirzepatide, and re-checking a rate if volume or SKU mix changes means another conversation.
A pass-through model inverts that. With Fizy Health, the resolved 503A landed cost appears on each catalog and cart line before checkout, and the platform's margin is a disclosed facilitation fee at payment rather than an opaque per-vial spread. The drug cost is what the 503A pharmacy charges; the platform fee is stated separately. For a clinic quoting cash-pay GLP-1, peptide, or hormone patients daily, that means the price you quote and the price you pay are the same visible number — no markup layer obscured inside the vial cost, no waiting on a revised quote.